Research assistant at the Biomimetic systems for cell engineering Research Group

Data límit: 20/06/2022
Ref: RA_EM

Biomimetic systems for cell engineering Group is looking for a for a Research Assistant. The contract will be within the framework of an ERC Proof-of-concept project (GUT3DPLATE), whose objective is the fabrication and validation of ready-to-use hydrogel in vitro models of tissue barriers using 3D bioprinting.

Reducing animal testing with 3D Bioprinting: European project BRIGHTER brings new light

The European project BRIGHTER, coordinated by IBEC, is developing a new technology to produce functional human tissues as an alternative to animal experimentation in the field of biomedical research. This light-based 3D bioprinting technology fabricates tissues by patterning three-dimensional cell cultures. In the future, it could be even used to produce organs in the laboratory.

Nanomedicine against cancer brings together hundred experts

Nanomed, the Spanish nanomedicine platform coordinated by the Institute for Bioengineering of Catalonia (IBEC), organized with the Germans Trias i Pujol Institute (IGTP), the sixth edition of a conference designed to present the advances against cancer, from early diagnosis and controlled drug release, up to nanoparticle radiation therapy.

Does 3D bioprinting improve cancer survival?

Elena Martínez, group leader at IBEC and professor at the University of Barcelona (UB), is interviewed for the Big Vang section of La Vanguardia expaining her project to develop organs on a chip to improve the survival of patients with colorectal tumor metastases.

Bioengineering against cancer: IBEC researchers receive funding from La Caixa

IBEC researchers Elena Martínez, Xavier Trepat and Pere Roca-Cusachs aim to understand the processes that promote metastasis in colorectal cancer using innovative bioengineering tools, such as bioprinting and microscopy capable of revealing forces at the cellular level.

The results will be translated into a device that will recreate the tumor environment from cancer cells derived from patients, as well as a new technology that will allow to visualize how physical forces affect the nuclei of metastatic cells.